Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
Recruiting · NCT05268692 · Interventional (participants receive a specific treatment) · Lead sponsor: Kochi University
View the official record on ClinicalTrials.gov →Interventions studied
GSGnP
What this trial is about
The effect of neoadjuvant chemotherapy for pancreatic cancer was gradually established. However it has been not clarified which regimen of neoadjuvant treatment for pancreatic cancer is the best.
Who can take part
Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2, Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- elective pancreatectomy for pancreatic cancer
Exclusion criteria
- a previous cancer surgery a body weight loss of \>10% during the 6 months before surgery the presence of distant metastases seriously impaired function of vital organs because of respiratory, renal, or heart disease.
Where it is running
1 location listed.
- Takehiro Okabayashi - Kochi, Japan